SCHEMBL30556296

SCHEMBL30556296

CN1CCN(C2CCN(c3ccc(Nc4ncc(Cl)c(-c5c[nH]c6ncccc56)n4)cc3Cl)CC2)CC1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 13/20 0.64
▸ JAK2 O60674 3/20 0.52
▸ JAK3 P52333 3/20 0.52
▸ JAK1 P23458 2/20 0.52
▸ TYK2 P29597 2/20 0.52
▸ CDK2 P24941 3/20 0.52
▸ IGF1R P08069 1/20 0.52
▸ DYRK1B Q9Y463 1/20 0.52
▸ CDK1 P06493 2/20 0.50
▸ KDR P35968 1/20 0.50
▸ CCNE1 P24864 2/20 0.48
▸ CCNT1 O60563 1/20 0.48
▸ CCNK O75909 1/20 0.48
▸ CDK9 P50750 1/20 0.48
▸ CDK12 Q9NYV4 1/20 0.48
▸ CCNB1 P14635 1/20 0.47
▸ FLT3 P36888 1/20 0.47
▸ CDK7 P50613 1/20 0.47
▸ CCNH P51946 1/20 0.47
▸ MNAT1 P51948 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22089721 1.00 EGFR (0.64) EGFRJAK2JAK3JAK1TYK2
SCHEMBL22104361 0.91 EGFR (0.70) EGFRJAK2JAK3JAK1TYK2
SCHEMBL30556289 0.91 EGFR (0.70) EGFRJAK2JAK3JAK1TYK2
SCHEMBL22104310 0.85 EGFR (0.70) EGFRJAK2JAK3JAK1TYK2
SCHEMBL30556281 0.85 EGFR (0.70) EGFRJAK2JAK3JAK1TYK2
SCHEMBL22104432 0.84 EGFR (0.62) EGFRJAK2JAK3JAK1TYK2
SCHEMBL30556290 0.84 EGFR (0.62) EGFRJAK2JAK3JAK1TYK2
SCHEMBL22104313 0.83 EGFR (0.78) EGFRJAK2JAK3JAK1TYK2
SCHEMBL30556280 0.83 EGFR (0.78) EGFRJAK2JAK3JAK1TYK2
SCHEMBL22104554 0.82 EGFR (0.66) EGFRJAK2JAK3JAK1TYK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113166110-B 2-aminopyrimidine compound and application thereof 暨南大学 2023-08-11 — — CN disclosed
Send feedback